Literature DB >> 12596249

Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.

Padma Kumar Narayanan1, Timothy Hart, Fiona Elcock, Cindy Zhang, Laura Hahn, David McFarland, Lester Schwartz, D Gwyn Morgan, Peter Bugelski.   

Abstract

BACKGROUND: Troglitazone (TRO), a thiazolidinedione (TZD) peroxisome proliferator-activated receptor gamma agonist, was recently withdrawn from the market because of rare but serious hepatotoxicity. Previous studies investigating the cytotoxicity of TRO in cultured rat hepatocytes have conjectured about the role of oxidative stress in TRO-induced hepatotoxicity. Therefore, we investigated whether TRO induces oxidative stress and, if so, the portion of the TRO molecule responsible for the induction of oxidative stress.
METHODS: Novikoff rat hepatoma (N1S1) cells were incubated with TRO, troglitazone quinone (TQ), thiazolidinedione-phenoxyacetic acid (TD-PAA) or rosiglitazone (RSG). Membrane peroxidation, intracellular glutathione (GSH) content, and cellular viability were monitored simultaneously by multiparameter flow cytometry.
RESULTS: TRO and TQ increased membrane peroxidation, decreased intracellular GSH, and decreased cell viability in a concentration-dependent manner. In contrast, TD-PAA and RSG neither increased membrane peroxidation nor induced loss of cell viability. In addition, TRO caused a concentration-dependent increase in intracellular superoxide generation accompanied by a collapse in mitochondrial membrane potential.
CONCLUSION: Multiparameter flow cytometric evaluation of N1S1 cells indicated that the chromane ring of TRO, rather than the TZD moiety, may be responsible for oxidative stress and suggested that a direct effect on mitochondrial physiology may play a role in TRO-mediated hepatotoxicity. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12596249     DOI: 10.1002/cyto.a.10011

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  13 in total

1.  Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

Authors:  D Konrad; A Rudich; P J Bilan; N Patel; C Richardson; L A Witters; A Klip
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

2.  15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells.

Authors:  W H Cho; C H Choi; J Y Park; S K Kang; Y K Kim
Journal:  Neurochem Res       Date:  2006-10       Impact factor: 3.996

3.  Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells.

Authors:  Alyssa M Keil; Douglas M Frederick; Erina Y Jacinto; Erica L Kennedy; Randy J Zauhar; Nathan M West; Ruy Tchao; Peter J Harvison
Journal:  Toxicol In Vitro       Date:  2015-07-17       Impact factor: 3.500

4.  Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet.

Authors:  Esen Akbay; Nuriye Nuray Ulusu; Füsun Töröner; Göksun Ayvaz; Ferit Taneri; Müjde Aktürk; Metin Arslan; Cimen Karasu
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

5.  Regulation and cytoprotective role of hexokinase III.

Authors:  Eugene Wyatt; Rongxue Wu; Wael Rabeh; Hee-Won Park; Mohsen Ghanefar; Hossein Ardehali
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

6.  Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.

Authors:  Lyudmila I Rachek; Larysa V Yuzefovych; Susan P Ledoux; Neil L Julie; Glenn L Wilson
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-24       Impact factor: 4.219

7.  Expression and functional activity of PPARgamma in pancreatic beta cells.

Authors:  Hannah J Welters; Stuart C McBain; Moh Tadayyon; John H B Scarpello; Stephen A Smith; Noel G Morgan
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

8.  Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.

Authors:  Dong Wan Kang; Chang Hwa Choi; Ji Yeon Park; Soo Kyung Kang; Yong Keun Kim
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

9.  Effect of troglitazone on radiation sensitivity in cervix cancer cells.

Authors:  Zhengzhe An; Xianguang Liu; Hyejin Song; Chihwan Choi; Won-Dong Kim; Jae-Ran Yu; Woo-Yoon Park
Journal:  Radiat Oncol J       Date:  2012-06-30

10.  PPARgamma in Kidney Physiology and Pathophysiology.

Authors:  Eva Kiss-Tóth; Tamás Roszer
Journal:  PPAR Res       Date:  2009-03-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.